Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Axogen, Inc. Director's Dealing 2023

Mar 21, 2023

32414_dirs_2023-03-20_6827c6da-25e9-4489-98e0-72f750262b41.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Axogen, Inc. (AXGN)
CIK: 0000805928
Period of Report: 2023-03-16

Reporting Person: MARTINEZ MARIA D. (Chief Human Resources Officer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2023-03-16 Common Stock M 3000 Acquired 22061 Direct
2023-03-16 Common Stock F 933 $8.27 Disposed 21128 Direct
2023-03-16 Common Stock M 1250 Acquired 22378 Direct
2023-03-16 Common Stock F 389 $8.27 Disposed 21989 Direct
2023-03-16 Common Stock M 4367 Acquired 26356 Direct
2023-03-16 Common Stock F 1358 $8.27 Disposed 24998 Direct
2023-03-16 Common Stock M 5900 Acquired 30898 Direct
2023-03-16 Common Stock F 1590 $8.27 Disposed 29308 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2023-03-16 Restricted Stock Units $ M 3000 Acquired Common Stock (3000.0) Direct
2023-03-16 Restricted Stock Units $ M 1250 Acquired Common Stock (1250.0) Direct
2023-03-16 Restricted Stock Units $ M 4367 Acquired Common Stock (4367.0) Direct
2023-03-16 Restricted Stock Units $ M 5900 Acquired Common Stock (5900.0) Direct
2023-03-16 Employee Stock Option (right to purchase) $8.27 A 66500 Acquired 2033-03-16 Common Stock (66500.0) Direct
2023-03-16 Employee Stock Option (right to purchase) $ A 46300 Acquired Common Stock (46300.0) Direct

Footnotes

F1: This reflects the number of restricted stock units that became vested as of March 16, 2023.

F2: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.

F3: Each restricted stock unit represents a contingent right to receive one share of Axogen, Inc. common stock.

F4: All shares of Axogen Inc. common stock underlying the restricted stock units will be fully vested on March 16, 2024 (4 years from the grant date) based upon a vesting schedule whereby 50% of the aggregate shares vest on March 16, 2022 (24 months from the grant date) and an additional 25% of the aggregate shares vest each 12 months thereafter. Vested shares will be delivered to the reporting person upon the vesting date.

F5: All shares of Axogen Inc. common stock underlying the restricted stock units will be fully vested on March 16, 2024 (3 years from the grant date) based upon a vesting schedule whereby 33.33% of the aggregate shares vest on March 16, 2022, 33.33% of the aggregate shares vest on March 16, 2023, and 33.34% of the aggregate shares vest on March 16, 2024. Vested shares will be delivered to the reporting person upon the vesting date.

F6: All shares of Axogen Inc. common stock underlying the restricted stock units will be fully vested on March 16, 2025 (4 years from the grant date) based upon a vesting schedule whereby 50% of the aggregate shares vest on March 16, 2023, 25% of the aggregate shares vest on March 16, 2024, and 25% of the aggregate shares vest on March 16, 2025. Vested shares will be delivered to the reporting person upon the vesting date.

F7: All shares of Axogen, Inc. common stock underlying the employee stock option will be fully vested on March 16, 2027 (4 years from the option grant date) based upon a vesting schedule whereby 50% of the aggregate shares vest on March 16, 2025 (24 months from the option grant date) and an additional 12.5% of the aggregate shares vest each 6 months thereafter.

F8: All shares of Axogen Inc. common stock underlying the restricted stock units will be fully vested on March 16, 2027 (4 years from the grant date) based upon a vesting schedule whereby 50% of the aggregateshares vest on March 16, 2025 (24 months from the grant date) and an additional 25% of the aggregate shares vest each 12 months thereafter. Vested shares will be delivered to the reporting person upon the vesting date.